NYSE - Delayed Quote
USD
AbbVie Inc. (ABBV)
291.31
+3.07
(+1.07%)
At close: November 6 at 4:01:45 PM EST
291.31
0.00
(0.00%)
After hours: November 6 at 6:26:03 PM EST
Trade AbbVie on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreAnalyst Insights
Top Analyst
Canaccord Genuity
89/100
Analyst Price Targets
Analyst Recommendations
-
Strong Buy
-
Buy
-
Hold
-
Underperform
-
Sell
Latest Rating
Date
11/2/2026
Analyst
UBS
Rating Action
Maintains
Rating
Neutral
Price Action
Raises
Price Target
275 -> 295
Top Analysts
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more| Analyst
|
Overall Score
|
Direction Score
|
Price Score
|
Latest Rating
|
Price Target
|
Date
|
|---|---|---|---|---|---|---|
|
Canaccord Genuity
|
89 | 91 | 100 | Buy
|
338 | 2026-11-03 |
|
Evercore ISI Group
|
69 | 68 | 100 | Outperform
|
260 | 2026-08-10 |
|
Cantor Fitzgerald
|
68 | 74 | 100 | Overweight
|
325 | 2026-11-03 |
|
RBC Capital
|
67 | 74 | 100 | Outperform
|
330 | 2026-11-03 |
|
Guggenheim
|
65 | 68 | 100 | Buy
|
322 | 2026-11-03 |
|
HSBC
|
64 | 64 | 93 | Buy
|
315 | 2026-09-10 |
|
Wells Fargo
|
63 | 71 | 100 | Overweight
|
340 | 2026-11-03 |
|
Piper Sandler
|
62 | 69 | 77 | Overweight
|
303 | 2026-08-20 |
|
Morgan Stanley
|
59 | 59 | 100 | Overweight
|
346 | 2026-11-02 |
|
Citigroup
|
57 | 58 | 84 | Neutral
|
260 | 2026-07-15 |
Rows per page
1-10 of 19
Upgrades & Downgrades
| Maintains | UBS: Neutral to Neutral | 11/2/2026 |
| Maintains | Leerink Partners: Outperform to Outperform | 11/2/2026 |
| Maintains | Morgan Stanley: Overweight to Overweight | 11/2/2026 |
| Maintains | Guggenheim: Buy to Buy | 11/2/2026 |
| Maintains | Wells Fargo: Overweight to Overweight | 11/2/2026 |
| Maintains | RBC Capital: Outperform to Outperform | 11/2/2026 |
